申请人:AKZO N.V.
公开号:US05171752A1
公开(公告)日:1992-12-15
The invention relates to a benzhydryl derivative having the formula ##STR1## wherein each of the groups R.sub.1, R.sub.2, and R.sub.3 represents one to four substituents independently selected from the group consisting of hydrogen, lower alkyl, halogen, and CF.sub.3, and at least one of the groups R.sub.1, R.sub.2, and R.sub.3 is halogen or CF.sub.3 ; R.sub.4 represents hydrogen or methyl; n is 2, 3, or 4; m is 1, 2, or 3; and X represents O or S; or its pharmaceutically acceptable salts. The benzhydryl derivative of the invention can be used to treat patients who are suffering from diseases which are influenced by calmodulin.
本发明涉及一种苯甲酰基衍生物,其化学式为##STR1## 其中,R.sub.1、R.sub.2和R.sub.3中的每个基团都表示从氢、低级烷基、卤素和CF.sub.3中独立选择的1-4个取代基,且R.sub.1、R.sub.2和R.sub.3中至少有一个基团是卤素或CF.sub.3;R.sub.4表示氢或甲基;n为2、3或4;m为1、2或3;X表示O或S;或其药学上可接受的盐。本发明的苯甲酰基衍生物可用于治疗受钙调蛋白影响的疾病患者。